Trimebutine maleate
Trikolon contains trimebutine maleate as the active substance. Trimebutine acts on the smooth muscles of the gastrointestinal tract, regulating its function (peristalsis). The action of the medicine depends on the functional state of the gastrointestinal tract, and the regulation of peristalsis covers the entire gastrointestinal tract. Trimebutine does not affect the central nervous system. Trikolon is used for symptomatic treatment of:
Before starting to use Trikolon, you should discuss it with your doctor, pharmacist, or nurse.
The use of Trikolon is not recommended in children under 12 years of age.
You should tell your doctor or pharmacist about all medicines that you are taking or have recently taken, as well as any medicines that you plan to take. In particular, you should inform your doctor if you are taking zotepine (an antipsychotic medicine).
See section 3.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before using this medicine. Pregnancy There are no sufficient studies to confirm the safety of trimebutine during pregnancy. For this reason, trimebutine is not recommended during the first trimester of pregnancy. It is not expected to have a harmful effect on the mother or child, but the use of trimebutine during the second or third trimester should only be considered if necessary. Breastfeeding The safety of trimebutine in breastfeeding women has not been established. Fertility There are no data on the effect of trimebutine on fertility.
Trikolon has no influence or negligible influence on the ability to drive and use machines.
If you have been diagnosed with an intolerance to some sugars, you should consult your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be used exactly as prescribed by your doctor. If you are unsure, you should consult your doctor or pharmacist. The medicine is taken orally. The recommended dose is 100 mg, 3 times a day, before meals. In justified cases, the dose can be increased to 600 mg per day in divided doses. The tablet should be swallowed whole, with a glass of water.
The medicine can be used in adolescents over 12 years of age in a dose not exceeding 6 mg/kg body weight per day.
In case of using a higher dose of the medicine than recommended, you should contact your doctor, who will prescribe the appropriate treatment.
You should not take a double dose to make up for a missed dose. If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Trikolon can cause side effects, although not everybody gets them.
If you experience any side effects, including any side effects not listed in this leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children. Store in a temperature below 25°C. Store in the original packaging to protect from light and moisture. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Trikolon, 100 mg, is a white, round, biconvex coated tablet with a diameter of 8 mm. One packaging of the medicine contains 30 or 100 coated tablets, in PVC/PVDC/Aluminum blisters in a cardboard box.
"PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK" S.A., 51-131 Wrocław, ul. Żmigrodzka 242 E
tel.: 22 742 00 22, e-mail: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.